Silberman David 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Silberman David
Chief Financial Officer
Transactions
- Award
Common Stock
[F1]2022-01-03+19,000→ 69,000 total - Award
Stock Option (right to buy)
[F2]2022-01-03+32,000→ 32,000 totalExercise: $13.89Exp: 2032-01-03→ Common Stock (32,000 underlying)
Footnotes (2)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 4,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
- [F2]The Stock Option will vest in 4 installments as follows: 8,000 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.
Signature
/s/ David Silberman|2022-01-05